TrialThe Journal of infectious diseases2022

Safety and Immunogenicity of Heterologous and Homologous 2-Dose Regimens of Adenovirus Serotype 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study.

Neil Goldstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.